CTLA4 and non-small cell lung carcinoma: For example, Nabet and colleagues, in a study involving 46 patients with metastatic NSCLC receiving ICI monotherapy or combined with CTLA-4 inhibitors, used NGS to detect ctDNA concentrations 4 weeks after the start of treatment.